China approves first domestically made mRNA vaccine for Covid


China has approved its first domestically produced messenger RNA (mRNA) Covid-19 jab, a vaccine that its developer said worked well against some recent variants, including the dominant strain in the United States.

The National Medical Products Administration (NMPA) approved the SYS6006 vaccine, developed by CSPC Pharmaceutical, for emergency use on Wednesday about a year after its clinical trials began, according to the company.

The new jab would be the first of its kind to be rolled out in the mainland market. China has not authorised any foreign-produced mRNA vaccines for its citizens.

The Hebei-based company said it tested the jabs on about 4,000 cases in a study from December 10 to January 18, and found the booster efficacy to be more than 85 per cent after two to four weeks.

The data has not been published in a peer-reviewed journal.

“Clinical study shows that SYS6006, either as a basic shot or booster shot, could consistently enhance the reactivity of T cells to various variants including Delta, Omicron BA.2 and BA.5 in a high and more enduring manner,” the statement said.

03:18

Beijing rejects US agency report saying Covid-19 likely emerged from Chinese lab leak

Beijing rejects US agency report saying Covid-19 likely emerged from Chinese lab leak

T cells are immune cells that coordinate immune responses and kill cells that are infected with viruses.

The jab also demonstrated a neutralising effect “very well” on highly transmissible Omicron strains like BF.7, BQ.1.1, and XBB.1.5 – the lineage that accounted for more than 90 per cent of variants circulating in the US – and CH.1.1, the company said.

While BA.5.2 and BF.7 comprise most cases in China, local or imported cases of BQ.1.1, XBB.1.5, and CH.1.1 were identified, according to the latest national data.

England to end pre-departure Covid test rule for arrivals from China

The shot also carries milder side effects – like fever and injection site soreness – with “significantly lower” frequency and severity of side effects in the elderly, according to the company.

mRNA vaccines – widely used in the rest of the world – use messenger RNA molecules to teach the body to generate specialised proteins and activate T cells to trigger an immune response.

The traditional vaccines that China has been deploying use inactivated, adenovirus-vectored or protein recombination technology.

The approval in China came after an annual political meeting known as the “ two sessions”, during which “more scientific, accurate, and effective prevention” of Covid-19 was an agenda item in the government work report.
In the first press conference held by the new State Council, China’s cabinet, Premier Li Qiang signalled the need to “speed up the development of new vaccines and drugs”.

Video: China’s Li Qiang shakes off Shanghai Covid chaos to become new premier

China saw one of the world’s biggest waves of Covid-19 this past winter after it suddenly dropped its stringent Covid restrictions. Although infection numbers began to level off about a month later, experts expected smaller and successive waves to follow over the next few months, and stressed that approvals for more effective vaccines should be sped up.

At least five other Chinese drug makers have said they are developing mRNA vaccines. Walvax and AIM Vaccine said they were conducting or had completed clinical trials, but development and administrative processes had been slow.

AWcorna, co-developed by Yuxi Walvax with Suzhou Abogen Biosciences and the Academy of Military Sciences, was authorised for emergency use in Indonesia in September last year but has not yet been approved for China.



Source link

Visited 1 times, 1 visit(s) today

Related Article

Explainer | Singapore trades Covid-Zero for ‘Covid Resilience’. How will it work?

Singapore will from September remove quarantine requirements for vaccinated travellers from Germany and Brunei, in a signal to the world it is cautiously reopening while managing the Covid-19 threat. By trading its previous Covid-Zero approach for a new policy of “Covid resilience”, the city state is setting itself apart from neighbours that are either still

Why China’s lockdown protests pose an unprecedented challenge to Beijing

While local protests in China over environmental, labour and land disputes are not uncommon, the rare wave of blank-paper protests that spilled across China’s wealthiest cities – all targeting President Xi Jinping’s zero-Covid policy – represents a challenge of the type the country’s leaders have not faced for decades. The protests erupted last weekend after

Nasal spray Covid-19 vaccine co-developed by Hong Kong scientists approved for emergency use in mainland China in ‘historic breakthrough’

A nasal spray Covid-19 vaccine co-developed by Hong Kong microbiologist Professor Yuen Kwok-yung and his team with a mainland China university and pharmaceutical firm has been approved for emergency use by the national authorities. Yuen, from the University of Hong Kong (HKU), on Monday night said the development was a “historic breakthrough”. “The biggest meaning

Opinion | How melding Hong Kong’s traditions and youthful energy can lift tourism

Coronavirus: mainland China’s easing should spur Hong Kong to ask for border reopening, business leaders and health experts say

Beijing’s long-awaited easing of coronavirus precautions has sparked hopes that Hong Kong may soon be able to fully reopen its border with mainland China, as well as do away with traveller entry restrictions, the city’s business leaders and health experts have said. Commerce sector lawmaker Jeffrey Lam Kin-fung, also a member of the key decision-making

Coronavirus: Hong Kong further eases isolation rules but ongoing surge in cases keeps city from lifting social-distancing measures over holidays

This story has been made freely available as a public service to our readers. Please consider supporting SCMP’s journalism by subscribing. Hong Kong has further eased its quarantine and isolation measures following mainland China’s major shift away from its zero-Covid policy, but a continuing surge in daily infections is keeping the city from lifting social-distancing

‘Bigger than just Covid vaccines’: US drug giant Moderna wants to collaborate with Hong Kong scientists on mRNA technology with local branch

US pharmaceutical giant Moderna is looking to collaborate with Hong Kong scientists on vaccine development after setting up a local manufacturing branch, with a long-term goal to tap into the mainland Chinese market. In an interview with the Post, Patrick Bergstedt, Moderna senior vice-president and head of emerging markets, said the Hong Kong subsidiary would

Singapore doctors expect more PCR testing as China eases Covid measures

Singapore healthcare providers are expecting a wave of travellers requiring pre-departure PCR coronavirus tests in the coming months as China eases its border measures. Unihealth handles around 100-150 swabs for such tests across its four clinics each week, and it expects these numbers to increase. Medical director and family doctor Xie Huizhuang said there had

Coronavirus: Hong Kong drops on-arrival PCR tests and vaccine pass, city set to reopen its border with mainland China on January 10 at the earliest

This story has been made freely available as a public service to our readers. Please consider supporting SCMP’s journalism by subscribing. Hong Kong will drop almost all Covid-19 measures starting from Thursday, including mandatory polymerase chain reaction (PCR) tests for arrivals, its vaccine pass scheme and quarantine requirements for close contacts, following similar action by

0
Would love your thoughts, please comment.x
()
x